Genomics of HIV/AIDS Drug Response and Co-Morbidities (R01)

The purpose of this funding opportunity announcement is to expand the use of high-throughput genotyping, genomic sequencing, and related genomic technologies, and generate resulting data resources widely available for research use, to improve the efficacy and safety and ease of use of HIV/AIDS therapies

and of non-HIV drugs used to treat HIV/AIDS patients, and to reduce HIV/AIDS-related comorbidities, coinfections, and complications.
Related Programs

Human Genome Research

Department of Health and Human Services


Agency: Department of Health and Human Services

Office: National Institutes of Health

Estimated Funding: Not Available





Obtain Full Opportunity Text:
http://grants.nih.gov/grants/guide/pa-files/PA-16-435.html

Additional Information of Eligibility:
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U. S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.

Non-domestic (non-U.S.) components of U. S. Organizations are eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Full Opportunity Web Address:
http://grants.nih.gov/grants/guide/pa-files/PA-16-435.html

Contact:
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV

Agency Email Description:
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

Agency Email:
FBOWebmaster@OD.NIH.GOV

Date Posted:
2016-09-19

Application Due Date:
2020-05-07

Archive Date:
2020-06-07



Social Entrepreneurship
Spotlight



This Social Innovation Helps Prevent Bed Sores in Wheelchair Users


This Social Innovation Helps Prevent Bed Sores in Wheelchair Users

Co-founders William Mann and David Mravyan devised the Sensimat during a mandatory project for their MBA at the Richard Ivey School of Business in Canada. Sensimat is a device that helps manage and assess pressure among wheelchair users.


Unable to select database



More Federal Domestic Assistance Programs


Grants to Reduce Domestic Violence, Dating Violence, Sexual Assault, and Stalking on Campus | Emergency Management Institute (EMI)_Resident Educational Program | Navajo-Hopi Indian Settlement Program | Drug Court Training and Technical Assistance | Water Conservation Field Services Program (WCFSP) |  Site Style by YAML | Grants.gov | Grants | Grants News | Sitemap | Privacy Policy


Edited by: Michael Saunders

© 2004-2020 Copyright Michael Saunders